Ever since cell therapies demonstrated potential in lupus and beyond, focus has shifted from oncology to advancing the first approved autoimmune cell therapy to market.

The 3rd Cell Therapy for Autoimmune Disease Summit returns at a transformative moment for this field, as autoimmune therapies stand poised to lead the next frontier of cell therapy innovation. Join your peers in spotlighting breakthroughs across CAR-T, Treg, NK and in vivo cell therapies, to gain end-to-end insights and navigate the dynamic, high-velocity road to market.

Uncover first-hand experiences from industry titans including Cabaletta Bio, Umoja Biopharma, Cartesian Therapeutics, Century Therapeutics, Artiva Biotherapeutics and Novartis, to accelerate your therapeutic progression and remain ahead of your peers.

From target selection and IND preparation to clinical trial design, patient recruitment, and long-term data, empower your teams to translate clinical promise into real breakthroughs.

View the event here.